On September 4, 2019 ImaginAb Inc., a clinical-stage immuno-oncology imaging company, reported that it is scheduled to attend and / or present at the following investor and scientific conferences in September and October 2019 (Press release, ImaginAb, SEP 4, 2019, View Source [SID1234539259]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
World Molecular Imaging Congress 2019
September 4-7, 2019, Palais des congrès de Montréal, Montréal, Canada
Dr. Anna Wu, Ph.D., Founder and Chief Scientific Officer, will be attending and hosting meetings.
ESMO Congress 2019
September 27 – 1 October, 2019, Fira Gran Via, Barcelona, Spain
Dr. Anna Wu and Dr Toni Ribas, Ph.D., ImaginAb Science Advisory Board Member and President-Elect for The American Association for Cancer Research (AACR) (Free AACR Whitepaper), will be attending and hosting meetings. In addition, ImaginAb’s commercial team led by Ivan Plavec, Chief Business Officer (CBO), will be hosting meetings and available at the ImaginAb Booth #477.
Cavendish Global Conference: The 2019 Phoenix BioHealth Impact Forum
October 2-3, 2019, University Of Arizona – Phoenix Biomedical Campus, Phoenix, AZ, USA
Ian Wilson, CEO, will be attending and hosting meetings.
2nd Annual Advances in Immuno-Oncology USA Congress
October 8-9, 2019, DoubleTree by Hilton Hotel, San Diego, CA, USA
Ian Wilson, CEO, will be chairing a Panel Discussion on ‘Technological Challenges In Clinical Studies’ on October 9 at 13.30 PDT, Room 4.
Ian Wilson will also be presenting a session on ‘Insights on Reverse Translation for Patient Stratification in Clinical Studies’ on October 9 at 16.30 PDT, Room 4.
This follows CBO Ivan Plavec’s Pre-Congress Webinar on August 29, 2019, entitled ‘How CD8 Imaging Is Useful To Pharma Regarding Drug Research And Clinical Decision Making’ which is available to download here.
Optimum 11th Annual Healthcare Investor Conference
October 17, 2019, Bloomberg Headquarters, 3 Queen Victoria St, London, UK
Ian Wilson, CEO, will be attending and hosting meetings along with ImaginAb Board Director and Non-Executive Director at NICE, Tim Irish.
For further information please contact:
ImaginAb
Ian Wilson, Salli Walker
Email: [email protected]
Phone: +1 310 645 1211
Optimum Strategic Communications
Mary Clark, Supriya Mathur, Manel Mateus
Email: [email protected]
Phone: +44 20 3950 9144